Saravanan Arumugam

477 total citations
8 papers, 339 citations indexed

About

Saravanan Arumugam is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Saravanan Arumugam has authored 8 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Saravanan Arumugam's work include Neurogenetic and Muscular Disorders Research (6 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (3 papers). Saravanan Arumugam is often cited by papers focused on Neurogenetic and Muscular Disorders Research (6 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (3 papers). Saravanan Arumugam collaborates with scholars based in Spain, Germany and United States. Saravanan Arumugam's co-authors include Zhaofa Xu, Yongchao Ma, Brittany M. Edens, Chuan He, Jing Su, Guo‐li Ming, Francisca Rojas, Caroline Vissers, Nimrod Miller and Hongjun Song and has published in prestigious journals such as Human Molecular Genetics, Cell Reports and Experimental Neurology.

In The Last Decade

Saravanan Arumugam

8 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saravanan Arumugam Spain 7 294 95 92 38 29 8 339
Elena Perenthaler United Kingdom 8 485 1.6× 53 0.6× 163 1.8× 72 1.9× 6 0.2× 12 576
Pierre Klein United Kingdom 8 660 2.2× 172 1.8× 40 0.4× 21 0.6× 62 2.1× 14 704
Rongrong Le China 9 541 1.8× 84 0.9× 12 0.1× 53 1.4× 16 0.6× 13 592
Raphaëlle Luisier United Kingdom 9 279 0.9× 32 0.3× 145 1.6× 13 0.3× 27 0.9× 16 415
Hongliang Ge China 9 149 0.5× 86 0.9× 25 0.3× 9 0.2× 7 0.2× 14 397
D.B. Dogini Brazil 9 252 0.9× 180 1.9× 47 0.5× 37 1.0× 3 0.1× 11 344
Valentina Potrich Italy 5 306 1.0× 100 1.1× 130 1.4× 15 0.4× 2 0.1× 6 372
Jun Fu China 9 194 0.7× 54 0.6× 35 0.4× 9 0.2× 3 0.1× 23 305
Jonas Cerneckis United States 6 236 0.8× 61 0.6× 8 0.1× 14 0.4× 7 0.2× 12 322
Ivone Bruno United States 7 392 1.3× 122 1.3× 24 0.3× 28 0.7× 3 0.1× 11 453

Countries citing papers authored by Saravanan Arumugam

Since Specialization
Citations

This map shows the geographic impact of Saravanan Arumugam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saravanan Arumugam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saravanan Arumugam more than expected).

Fields of papers citing papers by Saravanan Arumugam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saravanan Arumugam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saravanan Arumugam. The network helps show where Saravanan Arumugam may publish in the future.

Co-authorship network of co-authors of Saravanan Arumugam

This figure shows the co-authorship network connecting the top 25 collaborators of Saravanan Arumugam. A scholar is included among the top collaborators of Saravanan Arumugam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saravanan Arumugam. Saravanan Arumugam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kahl, Michael D., Zhaofa Xu, Saravanan Arumugam, et al.. (2024). m6A RNA methylation regulates mitochondrial function. Human Molecular Genetics. 33(11). 969–980. 11 indexed citations
2.
Armengol, José Á., Saravanan Arumugam, Mehri Moradi, et al.. (2022). SMN Is Physiologically Downregulated at Wild-Type Motor Nerve Terminals but Aggregates Together with Neurofilaments in SMA Mouse Models. Biomolecules. 12(10). 1524–1524. 6 indexed citations
3.
Edens, Brittany M., Caroline Vissers, Jing Su, et al.. (2019). FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export. Cell Reports. 28(4). 845–854.e5. 210 indexed citations
4.
Arumugam, Saravanan, Ana Garcerá, Rosa M. Soler, & Lucı́a Tabares. (2017). Smn-Deficiency Increases the Intrinsic Excitability of Motoneurons. Frontiers in Cellular Neuroscience. 11. 269–269. 10 indexed citations
5.
Arumugam, Saravanan, et al.. (2017). Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons. Molecular Neurobiology. 55(6). 5019–5030. 11 indexed citations
6.
Arumugam, Saravanan, et al.. (2016). Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Experimental Neurology. 283(Pt A). 287–297. 21 indexed citations
7.
Tejero, Rocío, et al.. (2016). Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Human Molecular Genetics. 25(21). ddw297–ddw297. 39 indexed citations
8.
Garcerá, Ana, et al.. (2013). Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro. Cell Death and Disease. 4(6). e686–e686. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026